Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Rapid Communications in Mass Spectrometry : RCM|March 7, 2007
Examination of the distribution of the bioreductive drug AQ4N and its active metabolite AQ4 in solid tumours by imaging matrix-assisted laser desorption/ionisation mass spectrometrySally J Atkinson, Paul M Loadman, Chris Sutton, et al.
The Analyst|August 13, 2016
An optimised assay for quantitative, high-throughput analysis of polysialyltransferase activitySara M Elkashef, Mark Sutherland, Laurence H Patterson, et al.
Biochemical Pharmacology|May 22, 2022
Targeted delivery of a colchicine analogue provides synergy with ATR inhibition in cancer cellsFrancis M Barnieh, Goreti Ribeiro Morais, Herbie Garland, et al.
Plos One|June 16, 2012
FGFR1-induced epithelial to mesenchymal transition through MAPK/PLCγ/COX-2-mediated mechanismsDarren C Tomlinson, Euan W Baxter, Paul M Loadman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 5, 2021
Cytochrome P450 Binding and Bioactivation of Tumor-Targeted Duocarmycin AgentsAaron G Bart, Goreti Morais, Venu R Vangala, et al.
Rapid Communications in Mass Spectrometry : RCM|September 26, 2015
Thin-layer chromatography/matrix-assisted laser desorption/ionisation mass spectrometry and matrix-assisted laser desorption/ionisation mass spectrometry imaging for the analysis of phospholipids in LS174T colorectal adenocarcinoma xenografts treated with the vascular disrupting agent DMXAAAfnan Batubara, Vikki A Carolan, Paul M Loadman, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 8, 2024
Hypoxia-Responsive Prodrug of ATR Inhibitor, AZD6738, Selectively Eradicates Treatment-Resistant Cancer CellsFrancis M Barnieh, Goreti Ribeiro Morais, Paul M Loadman, et al.
Urology|April 19, 2005
Expression of matrix metalloproteinase-10 in human bladder transitional cell carcinomaJill M Seargent, Paul M Loadman, Sandie W Martin, et al.
Obesity (Silver Spring, Md.)|April 30, 2013
Mucosal biomarkers of colorectal cancer risk do not increase at 6 months following sleeve gastrectomy, unlike gastric bypassPrashant Kant, Sarah L Perry, Simon P Dexter, et al.
Iscience|November 9, 2023
Cancer-specific glycosylation of CD13 impacts its detection and activity in preclinical cancer tissuesFrancis M Barnieh, Sebastian P Galuska, Paul M Loadman, et al.
Pageof 8